Previous close | 0.6400 |
Open | 0.6700 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 1.00 |
Expiry date | 2026-01-16 |
Day's range | 0.6400 - 0.6700 |
Contract range | N/A |
Volume | |
Open interest | 4.94k |
Key Insights Ginkgo Bioworks Holdings' Annual General Meeting to take place on 13th of June Salary of US$250.0k is part...
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that management will be participating in two investor conferences in May.
Sojitz, a large Japanese general trading company with extensive networks within the Japanese bioeconomy, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that they have entered into a binding definitive agreement. Together, Sojitz and Ginkgo aim to build connections with key Japanese businesses and encourage the use of synthetic biology to develop sustainable production processes.